Live feed17:00:19·446dINSIDERFilingvia QuantisnowChief Executive Officer Kathiresan Sekar converted options into 33,000 shares and sold $40,761 worth of shares (9,822 units at $4.15), increasing direct ownership by 7% to 346,686 units (SEC Form 4)ByQuantisnow·Wall Street's wire, on your screen.VERV· Verve Therapeutics Inc.Health CareOriginal source